# Nuvation Bio Inc. (NUVB): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Nuvation Bio Inc. (NUVB) is 23/100, ranked against 24,000+ stocks in 35 markets (Quality 31, Value 24, Momentum 51, each scored against its sector).

- StockRank: 23/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 31, Value 24, Momentum 51: each a 0-100 percentile within Healthcare.
- Position: #20,326 overall, #1,811 in Healthcare.
- Listing: United States, NYQ; Healthcare / Biotechnology.
- Last close: 4.51 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 118K; directors sold USD 2.1M.

Source: https://moatmap.ai/stock/NUVB
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker